SPHK1 and myeloid sarcoma: Our finding of high SphK1 expression by infiltrating macrophages and reactive astrocytes in MS lesions suggests that inhibition of SphK1 activity may be beneficial in MS by dampening macrophage- and astrocyte-mediated inflammation and tissue damage.